This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Years of investment in digital, cloud and security strategy has helped Accenture evolve as a trusted and viable consulting services provider. It is currently the world’s top consultancy firm by revenues that increased 5% in 2019 with a contribution of 56% from consulting services.
Brokers Suggest Investing in Accenture (ACN): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Accenture (ACN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Accenture PLC (ACN) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Accenture (ACN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Accenture (ACN) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
In the latest trading session, Accenture (ACN) closed at $363.04, marking a +0.48% move from the previous day.
Bitcoin Surpasses $71,000: Buy 4 Crypto Stocks With Growth Potential
by Ritujay Ghosh
Stocks like IBKR, CME, ACN and BLK are poised to benefit from the ongoing Bitcoin rally.
Is First Trust Rising Dividend Achievers ETF (RDVY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RDVY
UIS Stock Ahead of Q3 Earnings Report: To Buy or Not to Buy?
by Zacks Equity Research
Unisys' third-quarter 2024 results are expected to benefit from strong demand for Digital Workplace Solutions and Cloud-Based Solutions.
Is Unisys Stock a Buy, Sell or Hold at 0.19X Price/Sales Ratio?
by Aniruddha Ganguly
UIS is an attractive stock for growth-oriented investors, given its portfolio strength and strong partner base.
Can VRT's Q3 Earnings Beat & Raised 2024 View Push the Stock Higher?
by Zacks Equity Research
Vertiv's third-quarter 2024 results reflect strong order increase, solid organic growth and margin expansion.
Vertiv Holdings Co. (VRT) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Vertiv (VRT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Accenture (ACN) Stock Moves -0.31%: What You Should Know
by Zacks Equity Research
The latest trading day saw Accenture (ACN) settling at $370.63, representing a -0.31% change from its previous close.
Interpublic Group Earnings Meet Estimates in Q3, Revenues Miss
by Zacks Equity Research
IPG's third-quarter 2024 total revenues decline year over year. Earnings remain flat with the year-ago quarter.
3 Reasons Why Growth Investors Shouldn't Overlook Accenture (ACN)
by Zacks Equity Research
Accenture (ACN) possesses solid growth attributes, which could help it handily outperform the market.
Bitcoin on Track to Hit $70,000: 4 Crypto-Centric Stocks With Upside
by Ritujay Ghosh
Bitcoin-centric stocks like NVDA, CME, IBKR and ACN are poised to gain from the ongoing cryptocurrency rally.
The Zacks Analyst Blog Highlights AstraZeneca, Accenture, AT&T and National Presto Industries
by Zacks Equity Research
AstraZeneca, Accenture, AT&T and National Presto Industries are part of the Zacks top Analyst Blog.
Top Research Reports for AstraZeneca, Accenture & AT&T
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC (AZN), Accenture plc (ACN) and AT&T Inc. (T), as well as a micro-cap stock National Presto Industries, Inc. (NPK).
Omnicom Earnings & Revenues Surpass Estimates in Q3, Increase Y/Y
by Zacks Equity Research
Organic growth across the Experiential, Advertising & Media, Public Relations, and Brand & Retail Commerce segments fuels OMC's third-quarter 2024 revenues.
Investors Heavily Search Accenture PLC (ACN): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Accenture (ACN). This makes it worthwhile to examine what the stock has in store.
Wall Street Bulls Look Optimistic About Accenture (ACN): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Accenture (ACN). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Here's Why Accenture (ACN) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Ideas feature highlights: Nvidia, Taiwan Semiconductor and Accenture
by Zacks Equity Research
Nvidia, Taiwan Semiconductor and Accenture have been highlighted in this Investment Ideas article.
AI News: Blackwell Demand, OpenAI Raise
by Andrew Rocco
Many Wall Street Analysts are concerned that the AI spending sugar high will wear off. Stock Strategist Andrew Rocco explains how Nvidia's "insane demand" and OpenAI's massive valuation suggest that the bull market in AI spend is unlikely to subside soon.
Accenture PLC (ACN) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Accenture (ACN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The Zacks Analyst Blog Highlights Honeywell International, Accenture, City Holding and First United
by Zacks Equity Research
Honeywell International, Accenture, City Holding and First United are included in this Analyst Blog.
Should You Invest in the iShares U.S. Industrials ETF (IYJ)?
by Zacks Equity Research
Sector ETF report for IYJ
Time to Buy These 4 Stocks With Risking Dividend Yields?
by Ritujay Ghosh
Honeywell International (HON), Accenture (ACN), City Holding Company (CHCO) and First United (FUNC) recently announced dividend hikes.